Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07438912 · ClinicalTrials.gov registry record · NA

Mind After Midnight

A NA study of Suicidal Ideation and Sleep Deprivation, sponsored by University of Arizona.

Recruiting
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT07438912: Recruiting NA study of Suicidal Ideation and Sleep Deprivation, sponsored by University of Arizona.

NCT07438912 is a NA study of Suicidal Ideation and Sleep Deprivation that is actively recruiting participants, run by University of Arizona. The registered enrollment target is 90 participants, below the 267-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07438912, a NA study of Suicidal Ideation and Sleep Deprivation, is actively recruiting participants, sponsored by University of Arizona.

RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

This study examines whether wakefulness during the biological night (2:00-4:00 AM) is associated with increased negative mood, impaired decision-making, and suicidal thoughts. Adults with a history of suicidal ideation in the past six months will complete laboratory and home-based assessments under varying levels of sleep pressure. Participants will be evaluated during late-night wakefulness and under conditions of both higher and lower sleep pressure. The goal of the study is to better understand the biological and behavioral mechanisms that may contribute to elevated suicide risk during nocturnal wakefulness.

Primary Outcome

Total score on the BECK Hopelessness scale (BHS)

Interventions

  • BEHAVIORAL Sleep Pressure Manipulation

Study Locations (1)

Arizona

  • University of Arizona - Center for Sleep, Circadian, and Neuroscience Research - Tucson

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2026-03-01
Est. Completion 2029-08-31
Phase NA
University of Arizona

349 total trials

What NCT07438912 shows while recruiting

NCT07438912 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 267-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (66% lower).

The record links to 4 conditions, with Suicidal Ideation appearing as the primary indexed condition, and to 1 intervention - of which Sleep Pressure Manipulation is the first listed.

NCT07438912 reports a single indexed study location in Arizona.

Frequently Asked Questions

What is clinical trial NCT07438912 about?

NCT07438912 is a clinical study titled "Mind After Midnight". This study examines whether wakefulness during the biological night (2:00-4:00 AM) is associated with increased negative mood, impaired decision-making, and suicidal thoughts. Adults with a history of suicidal ideation in the past six months will complete laboratory and home-based assessments under ...

What is the current status of trial NCT07438912?

This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2026-03-01. Estimated completion is 2029-08-31.

What conditions does trial NCT07438912 study?

This clinical trial studies the following conditions: Suicidal Ideation, Sleep Deprivation, Circadian Rhythm Disorders, Sleep Wake Disorders.

What interventions are being tested in trial NCT07438912?

The interventions under investigation include: Sleep Pressure Manipulation (BEHAVIORAL).

Who is sponsoring clinical trial NCT07438912?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07438912 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicidal Ideation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07438912's enrollment target sits among peer trials

90 45th of 84 higher than 39 of 84 other Suicidal Ideation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Suicidal Ideation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07438912, the US trial registry maintained by the National Library of Medicine. NCT07438912 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.